The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1338
May 17, 2010
View Complete Issue         Table of Contents 2019 
Another Once-Daily Formulation of Tramadol (Ryzolt)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Another Once-Daily Formulation of Tramadol (Ryzolt)
May 17, 2010 (Issue: 1338)
The FDA has approved tramadol hydrochloride extended-release (Ryzolt – Purdue) for treatment of moderate to moderately severe chronic pain in adults. Tramadol is already available in another extended-release formulation (Ultram ER) and in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Another Once-Daily Formulation of Tramadol (Ryzolt)
Article code: 1338c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.